Last updated: March 1, 2023
Sponsor: CEN Biotech
Overall Status: Active - Recruiting
Phase
N/A
Condition
Ulcers
Venous Leg Ulcers
Treatment
N/AClinical Study ID
NCT04980898
C1633
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Venous leg ulcer evolving for at least 3 months, the area of which is between 4 cm²and 200 cm² and the smallest axis of which is less than 10 cm and the largest axisless than 20 cm;
- Have a Systolic Pressure Index (IPS) at the ankle between 0.89 and 1.3 and / or asystolic pressure measurement at the big toe greater than or equal to 60 mmHg;
- Accept the port of venous compression;
- Presenting superficial and / or deep venous insufficiency, documented on a Dopplerecho dating less than one year;
- affiliated to a social security scheme or beneficiary of such a scheme;
- Having given their free, informed and written consent.
Exclusion
Exclusion Criteria:
- Untreated infected wound;
- Cancerous ulcer;
- Treated with systemic corticosteroids or chemotherapy;
- for which a skin graft is necessary;
- Contraindications for the treatment of leg ulcers with the WoundEL system;
- Pregnant or lactating women;
- Vulnerable people or under legal/judicial protection
Study Design
Total Participants: 80
Study Start date:
March 16, 2021
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Centre Hospitalier Du Mans
Le Mans, 72037
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.